Krzysztof Brzózka

Company: Ryvu Therapeutics

Job title: Chief Scientific Officer

Seminars:

Exploring Next-Generation Payload Diversity Beyond Cytotoxics to Diversify Immune-oncology MOAs 9:15 am

Exploring an internal preclinical pipeline of small molecule payloads with conjugation potential Discussing matching target biology with payload choice and unique considerations for contemporary ADC design Differentiating modes of action and identifying therapeutic niches based off-targetRead more

day: Conference Day Two